REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Dentopharm Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: DENTOPHARM Egeszsegugyi Szolgaltato es Kereskedelmi Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Dentopharm Kft. is based in Hungary, with the head office in Napkor. The enterprise currently operates in the Pharmacies and Drug Stores sector. The company was established on June 25, 2010. 7 (2024) employees currently work for Dentopharm Kft.. From the latest financial highlights, Dentopharm Kft. reported a net sales revenue increase of 15.84% in 2023. Its total assets grew by 8.46% over the same period. The net profit margin of Dentopharm Kft. decreased by 9.9% in 2023.

Headquarters
Kossuth utca 7.
Napkor; Szabolcs-Szatmar-Bereg; Postal Code: 4552

Contact Details: Purchase the Dentopharm Kft. report to view the information.

Basic Information
Total Employees:
Purchase the Dentopharm Kft. report to view the information.
Outstanding Shares:
Purchase the Dentopharm Kft. report to view the information.
Registered Capital:
Purchase the Dentopharm Kft. report to view the information.
Financial Auditors:
Purchase the Dentopharm Kft. report to view the information.
Incorporation Date:
June 25, 2010
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Subsidiaries
Viridis-Pharma Kft.
Company Performance
Financial values in the chart are available after Dentopharm Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
15.84%▲
Total operating revenue
9.14%▲
Operating profit (EBIT)
-80.29%▼
EBITDA
-67.82%▼
Net Profit (Loss) for the Period
-90.1%▼
Total assets
8.46%▲
Total equity
4.32%▲
Operating Profit Margin (ROS)
-9.43%▼
Net Profit Margin
-9.9%▼
Return on Equity (ROE)
-39.47%▼
Quick Ratio
-0.49%▼
Cash Ratio
-0.32%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo